Conditions: HIV Infections
Keywords: treatment experienced
Allocation:  | Intervention model: PARALLEL
Enrollment: 11
Healthy volunteers: no

Brief summary:
The main purposes of this study are: demonstrate the safety and efficacy of TPV/r among HCV or hepatitis B virus (HBV) co-infected HIV+population, three-class (NRTI, NNRTI, and PI) experienced, with documented resistance to more than one PI. Determine pharmacokinetic data in this co-infected population and potential utility of using therapeutic drug monitoring (TDM) in improving efficacy outcomes.

Detailed description:

Arms:

Interventions: intervention 1: tipranavir intervention 2: ritonavir
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: